Stereochemistry | ABSOLUTE |
Molecular Formula | C5H11NO2S |
Molecular Weight | 149.211 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CSCC[C@@H](N)C(O)=O
InChI
InChIKey=FFEARJCKVFRZRR-SCSAIBSYSA-N
InChI=1S/C5H11NO2S/c1-9-3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-/m1/s1
Molecular Formula | C5H11NO2S |
Molecular Weight | 149.211 |
Charge | 0 |
Count |
MOL RATIO
1 MOL RATIO (average) |
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
D-Methionine is a stereoisomer of an essential proteinogenic sulfur-containing amino-acid L-methionine. D-methionine is an antioxidant, it demonstrated protective effects on cisplatin-induced anorexia and renal injury, and protected normal cells from radiation-induced cell death and from radiation-induced mucosal injury. In animal models, it protected against hearing loss induced by cisplatin, carboplatin, aminoglycosides, or noise exposure. A phase 3 clinical trial of D-methionine for prevention of hearing loss was conducted by the US Army, the study was terminated and no results were reported.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|